A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer A Multicentre Italian Trial in Ovarian cancer (MITO-5) studyPIGNATA, Sandro; BREDA, Enrico; PERRONE, Francesco et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 3, pp 229-236, issn 1040-8428, 8 p.Article

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III TrialPIGNATA, Sandro; SCAMBIA, Giovanni; VERNAGLIA LOMBARDI, Alessandra et al.Journal of clinical oncology. 2011, Vol 29, Num 27, pp 3628-3635, issn 0732-183X, 8 p.Article

Breakthrough Pain in Oncology: A Longitudinal StudyMERCADANTE, Sebastiano; ZAGONEL, Vittoria; LANZETTA, Gaetano et al.Journal of pain and symptom management. 2010, Vol 40, Num 2, pp 183-190, issn 0885-3924, 8 p.Article

Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian CancerFERRANDINA, Gabriella; LUDOVISI, Manuela; SCAMBIA, Giovanni et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 890-896, issn 0732-183X, 7 p.Article